• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期应用阿昔单抗对 ST 段抬高型心肌梗死患者梗死面积的影响。

Impact of early abciximab administration on infarct size in patients with ST-elevation myocardial infarction.

机构信息

Cardiothoracic and Vascular Department, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.

出版信息

Int J Cardiol. 2012 Mar 8;155(2):230-5. doi: 10.1016/j.ijcard.2010.09.094. Epub 2010 Oct 28.

DOI:10.1016/j.ijcard.2010.09.094
PMID:21035211
Abstract

BACKGROUND

Early abciximab administration in patients requiring transportation to undergo primary percutaneous coronary intervention (PPCI) has been reported to improve clinical outcome. We aimed to verify whether early administration leads to reduced infarct size (IS), assessed by delayed-enhancement magnetic resonance imaging (DE-MRI).

METHODS

We randomized 110 patients with acute myocardial infarction with symptom-to-diagnosis time <6h to either early (55 patients) or late (55 patients) abciximab administration. DE-MRI was performed at 4 days and 6 months. The primary end point was IS at 6 months. Secondary end points were the rate of ST-segment elevation resolution ≥ 50% (STR) at 60 min after PPCI, the extent of microvascular obstruction at 4 days, and the change in IS and transmurality at 6 months vs. 4 days.

RESULTS

DE-MRI was performed in 103 patients after 4 days, and in 87 at 6 months. The mean IS at 6 months was 13.8 ± 9.0% in the early vs. 13.0 ± 9.9% in the Late group (P>0.2). Similarly, microvascular obstruction and the change in IS were not significantly different. The Early group showed a significantly higher STR (94.5% vs. 80.0%, P=0.04) and a larger reduction in infarct transmurality (-9.2 ± 7.0% vs. -5.9 ± 6.4%; P=0.03), while a larger reduction in IS was observed only in patients with ECG-to-Cath Lab time >60 min.

CONCLUSIONS

Early abciximab administration did not lead to a smaller IS at 6-month DE-MRI, and was associated with a significant reduction in IS and transmurality only in patients with longer transportation time, warranting further investigation in this patient subset.

摘要

背景

有报道称,对于需要转院行直接经皮冠状动脉介入治疗(PPCI)的患者,早期给予阿昔单抗可改善临床结局。我们旨在验证早期给药是否可降低经延迟增强磁共振成像(DE-MRI)评估的梗死面积(IS)。

方法

我们将 110 例症状发作至诊断时间<6 h 的急性心肌梗死患者随机分为早期(55 例)和晚期(55 例)阿昔单抗给药组。在 4 天和 6 个月时进行 DE-MRI。主要终点是 6 个月时的 IS。次要终点是 PPCI 后 60 min 时 ST 段抬高缓解≥50%(STR)的发生率、4 天时的微血管阻塞程度,以及 6 个月时与 4 天时 IS 和透壁性的变化。

结果

在 4 天时,103 例患者进行了 DE-MRI,在 6 个月时,87 例患者进行了 DE-MRI。早期组的 6 个月时 IS 平均值为 13.8%±9.0%,晚期组为 13.0%±9.9%(P>0.2)。同样,微血管阻塞和 IS 的变化无显著差异。早期组的 STR 更高(94.5% vs. 80.0%,P=0.04),梗死透壁性降低更大(-9.2%±7.0% vs. -5.9%±6.4%;P=0.03),而仅在心电图至导管室时间>60 min 的患者中观察到 IS 降低更大。

结论

早期阿昔单抗给药并未导致 6 个月时 DE-MRI 的 IS 更小,仅在转运时间较长的患者中与 IS 和透壁性的显著降低相关,这需要在该患者亚组中进一步研究。

相似文献

1
Impact of early abciximab administration on infarct size in patients with ST-elevation myocardial infarction.早期应用阿昔单抗对 ST 段抬高型心肌梗死患者梗死面积的影响。
Int J Cardiol. 2012 Mar 8;155(2):230-5. doi: 10.1016/j.ijcard.2010.09.094. Epub 2010 Oct 28.
2
Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.经皮冠状动脉介入治疗联合血栓抽吸术治疗 ST 段抬高型心肌梗死患者中冠状动脉内与静脉内应用阿昔单抗的比较:ST 段抬高型心肌梗死紧急再灌注时冠状动脉内与静脉内应用阿昔单抗的比较(CICERO)试验。
Circulation. 2010 Dec 21;122(25):2709-17. doi: 10.1161/CIRCULATIONAHA.110.002741. Epub 2010 Nov 15.
3
Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial.在接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者中冠状动脉内注射与静脉推注阿昔单抗的比较:随机化的莱比锡直接经皮冠状动脉介入治疗ST段抬高型心肌梗死阿昔单抗静脉注射与冠状动脉内注射试验
Circulation. 2008 Jul 1;118(1):49-57. doi: 10.1161/CIRCULATIONAHA.107.747642. Epub 2008 Jun 16.
4
In-ambulance abciximab administration in STEMI patients prior to primary PCI is associated with smaller infarct size, improved LV function and lower incidence of heart failure: results from the Leiden MISSION! acute myocardial infarction treatment optimization program.在直接经皮冠状动脉介入治疗(PCI)前对ST段抬高型心肌梗死(STEMI)患者进行救护车内阿昔单抗给药与梗死面积减小、左心室功能改善及心力衰竭发生率降低相关:来自莱顿MISSION!急性心肌梗死治疗优化项目的结果。
Catheter Cardiovasc Interv. 2009 Aug 1;74(2):335-43. doi: 10.1002/ccd.21980.
5
Effects of early abciximab administration before primary percutaneous coronary intervention on left ventricular function assessed by cardiac magnetic resonance.在直接经皮冠状动脉介入治疗前早期给予阿昔单抗对通过心脏磁共振评估的左心室功能的影响。
Kardiol Pol. 2008 Jun;66(6):617-22; discussion 623.
6
Aspiration thrombectomy during primary percutaneous coronary intervention as adjunctive therapy to early (in-ambulance) abciximab administration in patients with acute ST elevation myocardial infarction: an analysis from Leiden MISSION! acute myocardial infarction treatment optimization program.急性 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗时行抽吸血栓术作为早期(救护车中)应用阿昔单抗辅助治疗:莱顿 MISSION!急性心肌梗死治疗优化项目的分析。
J Interv Cardiol. 2012 Feb;25(1):1-9. doi: 10.1111/j.1540-8183.2011.00686.x. Epub 2011 Nov 8.
7
Prehospital abciximab in ST-segment elevation myocardial infarction: results of the randomized, double-blind MISTRAL study.院前替罗非班在 ST 段抬高型心肌梗死中的应用:随机、双盲 MISTRAL 研究结果。
Circ Cardiovasc Interv. 2012 Feb 1;5(1):69-76, S1. doi: 10.1161/CIRCINTERVENTIONS.111.961425. Epub 2012 Feb 7.
8
Aborted myocardial infarction in intracoronary compared with standard intravenous abciximab administration in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.经皮冠状动脉介入治疗 ST 段抬高型心肌梗死患者中冠状动脉内与标准静脉内应用阿昔单抗比较的心肌梗死再发。
Int J Cardiol. 2011 Nov 17;153(1):21-5. doi: 10.1016/j.ijcard.2010.08.027. Epub 2010 Sep 6.
9
Periprocedural abciximab administration in ST elevation myocardial infarction patients. Effect on severe microvascular obstruction beyond the restoration of epicardial coronary flow by primary angioplasty.ST段抬高型心肌梗死患者围手术期使用阿昔单抗。对原发性血管成形术恢复心外膜冠状动脉血流后严重微血管阻塞的影响。
Cardiology. 2008;110(2):129-34. doi: 10.1159/000110492. Epub 2007 Oct 31.
10
Intracoronary compared to intravenous Abciximab and high-dose bolus compared to standard dose in patients with ST-segment elevation myocardial infarction undergoing transradial primary percutaneous coronary intervention: a two-by-two factorial placebo-controlled randomized study.经桡动脉入路直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者中冠状动脉内与静脉内应用阿昔单抗、大剂量弹丸式与标准剂量比较:一项两因素、安慰剂对照、随机研究。
Am J Cardiol. 2010 Jun 1;105(11):1520-7. doi: 10.1016/j.amjcard.2010.01.006. Epub 2010 Apr 14.

引用本文的文献

1
Acute Coronary Syndromes (ACS)-Unravelling Biology to Identify New Therapies-The Microcirculation as a Frontier for New Therapies in ACS.急性冠状动脉综合征(ACS)——揭示生物学以寻找新疗法——微循环作为 ACS 新疗法的前沿。
Cells. 2021 Aug 25;10(9):2188. doi: 10.3390/cells10092188.
2
Sonothrombolysis in the ambulance for ST-elevation myocardial infarction: rationale and protocol.ST段抬高型心肌梗死患者在救护车上进行超声溶栓治疗:原理与方案
Neth Heart J. 2021 Jun;29(6):330-337. doi: 10.1007/s12471-020-01516-9. Epub 2020 Nov 12.
3
Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future.
血小板 GP IIb-IIIa 受体拮抗剂在经皮冠状动脉介入治疗中的应用:回到未来。
Drugs. 2015 Jul;75(11):1229-53. doi: 10.1007/s40265-015-0425-7.
4
Intramyocardial haemorrhage after acute myocardial infarction.心肌梗死后心肌内出血。
Nat Rev Cardiol. 2015 Mar;12(3):156-67. doi: 10.1038/nrcardio.2014.188. Epub 2014 Nov 18.
5
Abciximab in the management of acute myocardial infarction with ST-segment elevation: evidence-based treatment, current clinical use, and future perspectives.阿昔单抗在ST段抬高型急性心肌梗死治疗中的应用:循证治疗、当前临床应用及未来展望
Ther Clin Risk Manag. 2014 Jul 18;10:567-76. doi: 10.2147/TCRM.S50002. eCollection 2014.
6
Strategies TO reduce time delays in patients with AcuTe coronary heart disease treated with primary PCI--the STOP WATCH study: a multistage action research project.策略以减少急性冠心病患者经皮冠状动脉介入治疗的时间延迟——STOP WATCH 研究:一个多阶段行动研究项目。
BMJ Open. 2013 Sep 3;3(9):e003493. doi: 10.1136/bmjopen-2013-003493.